Research, Select, & Monitor Tuesday, January 22, 2019 7:50:11 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
GoPro, Inc.$4.79($.12)(2.44%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  GoPro, Inc. vs Biotechnology

GoPro, Inc. engages in producing wearable HD camcorders, known as action cameras and related accessories. It also curates videos shot on its cameras and broadcasts those videos on its own channel on YouTube, Xbox Live and Virgin Atlantic flights. The company offers HERO line of cameras; premium accessories; and mounts comprising equipment-based mounts. It also offers other accessories that include spare batteries, charging accessories, cables to connect its GoPro cameras to televisions and monitors, video transmitters, external microphones, flotation devices, dive filters, and anti-fogging solutions, as well as accessories for the Wi-Fi remotes. GoPro, Inc. is headquartered in San Mateo, California.

An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: N/A $1,870.7 Mil
  Market Cap: $736.5 Mil $488,190.0 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
  Historic Revenue: N/A 148.4%
  Estimated Revenue: N/A 5.5%
  Historic Earnings: N/A 5.5%
  Estimated Earnings: N/A 2.2%
  Stock Price (1 Year): (21.7%) 11.3%
  Cash per Share: N/A 24.9%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 35.1 28.9
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 3.0
  Dividend Yield: N/A N/A
  Market Cap: $736.5 Mil $10,612.8 Mil
  Net Margin: N/A (1,648.2%)
  Gross Margin: N/A 75.0%
  Return on Equity: N/A .1
  Return on Assets: N/A (.2)
  Balance Sheet
  Current Ratio: N/A 3.9
  Quick Ratio: N/A 2.9
  Cash Ratio: N/A 2.1
  Debt-to-Equity: N/A .3
  Interest Coverage: N/A (.3)
  Relative-Strength Index: 51.8 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $203.88 $129,916.4 Mil
  Gilead Sciences, Inc.  (GILD) $69.18 $89,492.6 Mil
  Biogen Inc.  (BIIB) $337.42 $67,983.4 Mil
  Celgene Corp.  (CELG) $86.27 $60,324.3 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $418.84 $45,322.7 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.